SE421698B - Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat - Google Patents

Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat

Info

Publication number
SE421698B
SE421698B SE7607201A SE7607201A SE421698B SE 421698 B SE421698 B SE 421698B SE 7607201 A SE7607201 A SE 7607201A SE 7607201 A SE7607201 A SE 7607201A SE 421698 B SE421698 B SE 421698B
Authority
SE
Sweden
Prior art keywords
tieno
tetrahydro
preparing
procedure
pyridine derivatives
Prior art date
Application number
SE7607201A
Other languages
English (en)
Swedish (sv)
Other versions
SE7607201L (sv
Inventor
J-P Maffrand
Original Assignee
Parcor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor filed Critical Parcor
Publication of SE7607201L publication Critical patent/SE7607201L/xx
Publication of SE421698B publication Critical patent/SE421698B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
SE7607201A 1975-06-27 1976-06-23 Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat SE421698B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7520241A FR2315274A1 (fr) 1975-06-27 1975-06-27 Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications

Publications (2)

Publication Number Publication Date
SE7607201L SE7607201L (sv) 1976-12-28
SE421698B true SE421698B (sv) 1982-01-25

Family

ID=9157178

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7607201A SE421698B (sv) 1975-06-27 1976-06-23 Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat

Country Status (26)

Country Link
US (1) US4075340A (nl)
JP (1) JPS607633B2 (nl)
AR (1) AR211777A1 (nl)
AT (1) AT347950B (nl)
BE (1) BE843402A (nl)
CA (1) CA1071635A (nl)
CH (1) CH596169A5 (nl)
DD (1) DD125080A5 (nl)
DE (1) DE2628045A1 (nl)
DK (1) DK279976A (nl)
ES (1) ES449191A1 (nl)
FR (1) FR2315274A1 (nl)
GB (1) GB1492239A (nl)
GR (1) GR60042B (nl)
HU (1) HU172697B (nl)
IE (1) IE43915B1 (nl)
IL (1) IL49702A (nl)
LU (1) LU75230A1 (nl)
MX (1) MX3565E (nl)
NL (1) NL183032C (nl)
PL (1) PL105962B1 (nl)
PT (1) PT65271B (nl)
SE (1) SE421698B (nl)
SU (1) SU628820A3 (nl)
YU (1) YU39480B (nl)
ZA (1) ZA763270B (nl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127580A (en) * 1975-02-07 1978-11-28 Parcor Process for the preparation of thieno-pyridine derivatives
FR2395271A1 (fr) * 1977-06-21 1979-01-19 Parcor Procede de preparation de thieno (2,3-c) et thieno (3,2-c) pyridines
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
US4749692A (en) * 1977-06-22 1988-06-07 Sanofi, S.A. Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity
FR2397417A1 (fr) * 1977-07-12 1979-02-09 Parcor Procede de preparation de derives de la thienopyridine
AT368504B (de) * 1977-10-15 1982-10-25 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine
US4321266A (en) * 1980-10-06 1982-03-23 Sanofi 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine
FR2508453A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de derives des (thienyl-2)- et thienyl-3)-2 ethylamines et produits ainsi obtenus
US4547514A (en) * 1983-12-05 1985-10-15 A. H. Robins Company, Incorporated Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity
DE3736664A1 (de) * 1987-10-29 1989-05-11 Boehringer Ingelheim Kg Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
WO2000000472A1 (en) 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 5-ht7 receptor antagonists
US6090797A (en) * 1998-09-02 2000-07-18 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
AU5154699A (en) * 1998-09-02 2000-03-27 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
EP1487494A2 (en) * 2002-02-26 2004-12-22 North Shore-Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
WO2005092308A2 (en) 2004-03-25 2005-10-06 The Feinstein Institute For Medical Research Neural tourniquet
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
AU2005323463B2 (en) 2004-12-27 2009-11-19 The Feinstein Institutes For Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
WO2009029614A1 (en) 2007-08-27 2009-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
WO2009146030A1 (en) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
AU2009316801C1 (en) 2008-11-18 2015-12-24 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflammatory stimulation
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP2440284B1 (en) 2009-06-09 2018-09-12 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
WO2014169145A1 (en) 2013-04-10 2014-10-16 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
CN105126248B (zh) 2009-12-23 2018-06-12 赛博恩特医疗器械公司 用于治疗慢性炎症的神经刺激设备和系统
WO2012154865A2 (en) 2011-05-09 2012-11-15 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
CA2868356C (en) 2012-03-23 2020-06-23 Memorial Sloan-Kettering Cancer Center Treatment of pancreatic and related cancers with 5-acyl-6,7-dihydrothieno[3,2-c]pyridines
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US10011585B2 (en) 2014-07-28 2018-07-03 Merck Sharp & Dohme Corp. Factor XIa inhibitors
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
WO2017127758A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
CN108882885A (zh) 2016-01-20 2018-11-23 赛博恩特医疗器械公司 迷走神经刺激的控制
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
KR20230012585A (ko) 2020-05-21 2023-01-26 더 파인스타인 인스티튜츠 포 메디칼 리서치 미주 신경 자극을 위한 시스템들 및 방법들

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (nl) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
BE843402A (fr) 1976-12-27
GR60042B (en) 1978-04-01
GB1492239A (en) 1977-11-16
MX3565E (es) 1981-03-13
AU1537576A (en) 1978-01-05
NL7606574A (nl) 1976-12-29
NL183032C (nl) 1988-07-01
SE7607201L (sv) 1976-12-28
SU628820A3 (ru) 1978-10-15
CA1071635A (en) 1980-02-12
ES449191A1 (es) 1977-12-01
PL105962B1 (pl) 1979-11-30
DK279976A (da) 1976-12-28
ATA461776A (de) 1978-06-15
YU146276A (en) 1982-05-31
YU39480B (en) 1984-12-31
AR211777A1 (es) 1978-03-15
ZA763270B (en) 1977-05-25
IL49702A0 (en) 1976-08-31
CH596169A5 (nl) 1978-02-28
PT65271B (fr) 1977-12-10
DE2628045A1 (de) 1977-01-20
AT347950B (de) 1979-01-25
NL183032B (nl) 1988-02-01
HU172697B (hu) 1978-11-28
PT65271A (fr) 1976-07-01
JPS607633B2 (ja) 1985-02-26
LU75230A1 (nl) 1977-02-18
DD125080A5 (nl) 1977-03-30
IE43915B1 (en) 1981-07-01
US4075340A (en) 1978-02-21
IE43915L (en) 1976-12-27
IL49702A (en) 1979-01-31
JPS525793A (en) 1977-01-17
FR2315274A1 (fr) 1977-01-21
FR2315274B1 (nl) 1979-08-10

Similar Documents

Publication Publication Date Title
SE421698B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat
SE421623B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(2,3-c respektive 3,2-c)-pyridinderivat
SE434049B (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
SE416203B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-furo (respektive - tieno)-(3,2-c)pyridinderivat
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE432928B (sv) Forfarande for framstellning 4,5,6-trinor-3,7-inter-m-fenylen-pge, och vissa derivat derav
SE421795B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c)pyridin-derivat
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
SE428684B (sv) Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner
PL191674A1 (pl) Sposob wytwarzania nowych pochodnych tiazolo(3,4-b)izochinoliny
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
DK360576A (da) Fremgangsmade til fremstilling af pyridinderivater
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE423902B (sv) Forfarande for framstellning av purinderivat
SE421622B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c)-pyridinderivat
SE422579B (sv) Forfarande for framstellning av 4-oxo-hexahydro-pyrazino(2,1-a)isokinolinderivat
SE422324B (sv) Forfarande for framstellning av 3,4-dihydro-2(1h)-kinazolinderivat
SE421529B (sv) Forfarande for framstellning av tieno(3,2-c)pyridin-derivat
SE426585B (sv) Forfarande for framstellning av vissa aminoalkylbicyklo (2.2.2) oktanderivat
SE421700B (sv) Forfarande for framstellning av 2-alkoxikarbonyl-4,5,6,7-tetrahydrotieno(3,2-c)pyridinderivat
AR211854A1 (es) Procedimiento de preparacion de derivados polisustituidos de 10-piperazinodibenzo(b,f)tiepina
SE421699B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c respektive 2,3-c)-pyridinderivat
SE419222B (sv) Forfarande for framstellning av derivat av oxatiino (1,4)(2,3-c) pyrrol
NL181432C (nl) Werkwijze ter bereiding van 4,5,6,7-tetrahydrothieno(3,2-c)pyridinederivaten.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7607201-6

Effective date: 19940110

Format of ref document f/p: F